ILMN
Illumina, Inc.
Laboratory Analytical Instruments- 売上
- $4.3bn
- 時価総額
- $32.5bn
株価 $205.09 · 100株 2万円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $4.5bn | $4.4bn | $4.3bn |
| 成長率 | — | ▲2.9% | ▲0.7% |
| 総利益 | $2.7bn | $2.9bn | $2.9bn |
| 総利益率 | 60.9% | 65.4% | 66.1% |
| 販管費 | $1.6bn | $1.1bn | $1.1bn |
| 販管費率 | 35.8% | 25.0% | 25.0% |
| 営利 | ▲$1.1bn | ▲$833m | $807m |
| 営利率 | ▲23.7% | ▲19.1% | 18.6% |
| 純利益 | ▲$1.2bn | ▲$1.2bn | $850m |
| PBR | 5.7 | 13.7 | 11.9 |
| PSR | 7.2 | 7.4 | 7.5 |
| PGPR | 11.8 | 11.4 | 11.3 |
| PER | — | — | 38 |
| ﾈｯﾄｷｬｯｼｭ | ▲$856m | ▲$857m | ▲$857m |
| EV/EBITDA | — | — | 31.0 |
| Rule of 40 | — | ▲22% | 18% |
| セールス効率 | — | — | — |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）